# CFC1

## Overview
CFC1 is a gene that encodes the protein cryptic, EGF-CFC family member 1, which is a crucial component of the epidermal growth factor-Cripto/FRL-1/Cryptic (EGF-CFC) family. This protein functions as a co-receptor in the Nodal signaling pathway, playing a significant role in embryonic development, particularly in the establishment of the left-right (L-R) axis in vertebrates. The cryptic protein is characterized by an epidermal growth factor (EGF)-like domain and a cysteine-rich CFC domain, which are essential for its structural integrity and function. These domains facilitate its role in cellular localization and interaction with other proteins in the Nodal signaling pathway, ensuring proper organ positioning and development. Mutations in the CFC1 gene can lead to congenital disorders such as heterotaxy syndrome and various congenital heart defects, underscoring its clinical significance in developmental biology (Bamford2000Lossoffunction; Yan1999Conserved; Ravisankar2011Molecular).

## Structure
The CFC1 gene encodes a protein that is a member of the EGF-CFC family, characterized by an epidermal growth factor (EGF)-like domain and a cysteine-rich CFC domain. These domains are crucial for the protein's function as a co-receptor in the Nodal signaling pathway, which is important for embryonic development (Ravisankar2011Molecular). The EGF domain is highly conserved, containing a characteristic set of six cysteines that form a canonical disulfide arrangement, which is essential for maintaining the domain's structure (Ravisankar2011Molecular). The CFC domain also contains six conserved cysteines, forming a distinct disulfide pattern that contributes to its structural integrity (Ravisankar2011Molecular).

CFC1 is known to undergo post-translational modifications, such as glycosylation, which can influence its function and stability. The protein can exist in both glycosylphosphatidylinositol (GPI)-anchored and soluble forms, with the GPI-anchor facilitating its attachment to the cell membrane (Watanabe2008Characterization). The presence of splice variant isoforms of CFC1 suggests that alternative splicing may lead to different functional outcomes, although specific details on these isoforms are not provided in the context. The protein's structure and modifications are integral to its role in developmental processes.

## Function
The CFC1 gene encodes the CRYPTIC protein, a member of the EGF-CFC family, which plays a crucial role in embryonic development, particularly in establishing the left-right (L-R) axis in vertebrates, including humans. The CRYPTIC protein functions as a co-factor for Nodal-related signals, which are essential for L-R axis development. This signaling pathway is vital for the correct positioning of internal organs such as the heart, stomach, spleen, liver, and gall bladder (Bamford2000Lossoffunction).

In healthy human cells, the CRYPTIC protein is involved in cellular localization and function, facilitated by its structural features, including a functional signal peptide, a hydrophobic carboxy terminus for membrane association, and conserved EGF and CFC domains (Bamford2000Lossoffunction). These features enable the protein to participate effectively in Nodal signaling pathways, ensuring proper organ positioning and development (Bamford2000Lossoffunction).

The absence or malfunction of EGF-CFC activity, including that of CRYPTIC, can lead to defects in Nodal signaling, resulting in L-R laterality defects such as heterotaxia, where organ positioning is randomized (Yan1999Conserved). This highlights the critical role of CFC1 in maintaining the integrity of developmental processes that determine organ asymmetry.

## Clinical Significance
Mutations in the CFC1 gene are associated with several congenital disorders, primarily affecting the heart and the arrangement of internal organs. CFC1 mutations have been linked to heterotaxy syndrome, a condition characterized by the abnormal arrangement of internal organs along the left-right axis. This syndrome often involves complex congenital heart defects and is genetically heterogeneous, with CFC1 being one of the implicated genes (Bamford2000Lossoffunction; Cao2015Duplication).

In addition to heterotaxy syndrome, CFC1 mutations are associated with specific congenital heart defects such as transposition of the great arteries (TGA) and double-outlet right ventricle (DORV). These conditions are types of conotruncal defects, which involve the outflow tracts of the heart (Goldmuntz2002CFC1). The mutations in CFC1 can disrupt essential domains of the protein, leading to a loss of function and contributing to these cardiac malformations (Goldmuntz2002CFC1).

Furthermore, studies have identified CFC1 variants in patients with non-syndromic congenital heart disease, such as atrial septal defect (ASD) and ventricular septal defect (VSD), suggesting a role in the etiology of these conditions (Wang2011CFC1). However, CFC1 variants are considered a rare cause of congenital heart disease in patients without laterality defects (Özcelik2006Mutations).

## Interactions
CFC1, also known as CRYPTIC, is involved in several key interactions that are crucial for its role in embryonic development, particularly in left-right axis formation. CFC1 acts as a co-factor in the NODAL signaling pathway, which is essential for proper left-right patterning. It interacts with NODAL, a member of the TGF-beta family, facilitating its signaling by acting as a co-receptor (Bamford2000Lossoffunction). 

CFC1 is part of the EGF-CFC family, which includes proteins that serve as co-receptors for TGF-beta signals like NODAL and Vg1/GDF1. These interactions are necessary for the activation of Activin receptors, which are critical for signal transduction in embryonic development (Cheng2004Lefty). 

The protein also interacts with Lefty, a TGF-beta antagonist. Lefty competes with NODAL for binding to EGF-CFC coreceptors, such as Cripto, thereby inhibiting NODAL signaling. This interaction is specific, as Lefty does not bind to Activin receptors, highlighting the selective nature of CFC1's involvement in these pathways (Cheng2004Lefty). 

These interactions underscore the importance of CFC1 in modulating key signaling pathways that govern embryonic development and left-right axis determination.


## References


[1. (Bamford2000Lossoffunction) Richard N. Bamford, Erich Roessler, Rebecca D. Burdine, Umay Şaplakoğlu, June dela Cruz, Miranda Splitt, Jeffrey Towbin, Peter Bowers, Bruno Marino, Alexander F. Schier, Michael M. Shen, Maximilian Muenke, and Brett Casey. Loss-of-function mutations in the egf-cfc gene cfc1 are associated with human left-right laterality defects. Nature Genetics, 26(3):365–369, November 2000. URL: http://dx.doi.org/10.1038/81695, doi:10.1038/81695. This article has 268 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/81695)

[2. (Cao2015Duplication) Ruixue Cao, Fei Long, Liping Wang, Yuejuan Xu, Ying Guo, Fen Li, Sun Chen, Kun Sun, and Rang Xu. Duplication and deletion of cfc1 associated with heterotaxy syndrome. DNA and Cell Biology, 34(2):101–106, February 2015. URL: http://dx.doi.org/10.1089/dna.2014.2616, doi:10.1089/dna.2014.2616. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/dna.2014.2616)

[3. (Yan1999Conserved) Y.-T. Yan, K. Gritsman, J. Ding, R. D. Burdine, J. D. Corrales, S. M. Price, W. S. Talbot, A. F. Schier, and M. M. Shen. Conserved requirement for egf-cfc genes in vertebrate left-right axis formation. Genes &amp; Development, 13(19):2527–2537, October 1999. URL: http://dx.doi.org/10.1101/gad.13.19.2527, doi:10.1101/gad.13.19.2527. This article has 204 citations.](https://doi.org/10.1101/gad.13.19.2527)

[4. (Cheng2004Lefty) Simon K Cheng, Felix Olale, Ali H Brivanlou, and Alexander F Schier. Lefty blocks a subset of tgfβ signals by antagonizing egf-cfc coreceptors. PLoS Biology, 2(2):e30, February 2004. URL: http://dx.doi.org/10.1371/journal.pbio.0020030, doi:10.1371/journal.pbio.0020030. This article has 119 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.0020030)

[5. (Wang2011CFC1) Binbin Wang, Jing Wang, Shiguo Liu, Xiaoyang Han, XiaoDong Xie, You Tao, Jinting Yan, and Xu Ma. Cfc1 mutations in chinese children with congenital heart disease. International Journal of Cardiology, 146(1):86–88, January 2011. URL: http://dx.doi.org/10.1016/j.ijcard.2009.07.034, doi:10.1016/j.ijcard.2009.07.034. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ijcard.2009.07.034)

[6. (Watanabe2008Characterization) Kazuhide Watanabe, Tadahiro Nagaoka, Luigi Strizzi, Mario Mancino, Monica Gonzales, Caterina Bianco, and David S. Salomon. Characterization of the glycosylphosphatidylinositol-anchor signal sequence of human cryptic with a hydrophilic extension. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1778(12):2671–2681, December 2008. URL: http://dx.doi.org/10.1016/j.bbamem.2008.09.011, doi:10.1016/j.bbamem.2008.09.011. This article has 8 citations.](https://doi.org/10.1016/j.bbamem.2008.09.011)

[7. (Özcelik2006Mutations) Cemil Özcelik, Nana Bit-Avragim, Anna Panek, Ursula Gaio, Christian Geier, Peter E. Lange, Rainer Dietz, Maximilian G. Posch, Andreas Perrot, and Brigitte Stiller. Mutations in the egf-cfc gene cryptic are an infrequent cause of congenital heart disease. Pediatric Cardiology, 27(6):695–698, October 2006. URL: http://dx.doi.org/10.1007/s00246-006-1082-0, doi:10.1007/s00246-006-1082-0. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00246-006-1082-0)

[8. (Goldmuntz2002CFC1) Elizabeth Goldmuntz, Richard Bamford, Jayaprakash D. Karkera, June dela Cruz, Erich Roessler, and Maximilian Muenke. Cfc1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. The American Journal of Human Genetics, 70(3):776–780, March 2002. URL: http://dx.doi.org/10.1086/339079, doi:10.1086/339079. This article has 154 citations.](https://doi.org/10.1086/339079)

[9. (Ravisankar2011Molecular) V. Ravisankar, Taran P. Singh, and Narayanan Manoj. Molecular evolution of the egf–cfc protein family. Gene, 482(1–2):43–50, August 2011. URL: http://dx.doi.org/10.1016/j.gene.2011.05.007, doi:10.1016/j.gene.2011.05.007. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2011.05.007)